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Friday evening, 5.35 pm, in the main bar of the Bulls
and Bears in the City (London), a favourite watering
hole of Financial Masters of the Universe5 and
would-be FMUs:
Bondage, nonchalantly leaning against the bar: Hi, I
guess that the red carnation you are sporting indicates
that you are the gentleman from Menacyn. Bondage, at
your service!
von Spectre: My goodness, public schoolboys are
indeed forward!
Bondage: Very droll! My name is Bondage, James
Bondage.
von Spectre: Sorry, unable to resist! Good evening
James, my name is Mamba von Spectre, but you can
call me Mam. Shall we sit in that inconspicuous corner
over there where everyone can see us but, with this
happy hour noise, no-one can hear us. Let us have a
drink – my friends checked this place out in advance
and it seems to be reasonably safe.
Bondage: Sure – let’s have a J€ager-Train6 between us;
then we can be reasonably sure that our drink does not
contain anything untoward.
von Spectre: Good idea. Miss! We’d like a J€ager-Train–
a 10-er should initially sufﬁce.
A few minutes later, after chairs around the corner table
are re-, and re-, and re-arranged to provide both with
adequate lines of sight to the multiple entrances and
other doors:
Bondage: So Mam. . . what does Menacyn have in mind
this time that requires the attention of Her Majesty’s
Secret Service?
von Spectre: Ah, James – you always get straight to
the point, unlike the fetching and ever-so diplomatic
Miss Geld-Groschen. . .. . . HM Secret Service, did you
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say? MIH577 is more like HM Unsecret Service, after
our friends at Wackidribbles did their public-spirited
work.
Ok, just a bit of background to put you in the picture. As
you are almost certainly aware, recent research has
shown that human milk contains a remarkable number of
a type of compound called human milk oligosaccharides,
or HMOs, which, unexpectedly, do not nourish the baby,
but instead serve as food for intestinal microbes with the
moniker Biﬁdobacterium, or Bif for short8. Breast feeding
thus provides a continual selective advantage for Bif,
which has otherwise to compete with other bugs that
ordinarily colonise the infant intestine.
And the neat thing is: Bif, unlike these other bugs,
orchestrates correct development of the immune system,
which is essential for optimal protection against infections
and development of allergies8. Apparently, Bif is a very
hairy bug, having appendages called tight adherence pili
and sortase-dependent pili, and special polymers of
sugars, that establish intimate contacts with the infant
intestinal surfaces and mediate the bacterium:host
dialogues, that are key to correct development of the
immune and inﬂammatory systems. Cow’s milk, though
nutritious for infants, does not select for Bif, and the other
bugs that colonise the infant intestine are not nearly as
effective at building an effective immune system.
Thus: without Bif in infancy, people are less effective at
handling infections and are much more prone to develop
allergies. Are you following me?
Bondage: Of course – this is common knowledge.
von Spectre: Good! What is not common knowledge is
that Menacyn scientists have developed an anti-Bif virus
cocktail that kills all known biﬁdobacteria, except one, a
designer Bif that Menacyn researchers have created and
named Menacynbif. Menacynbif can only grow when
provided with a secret baby formula we have developed
in parallel, and called Bifgro. We have packaged the
phage cocktail in a microcapsule that ensures virus
survival under all the different conditions that might be
encountered in the various routes we plan for delivery,
but that dissolves in the intestine to release the virus.
Without Bif, the world will become more susceptible to
mild common infections, like ﬂu, and nuisance allergies.
Furthermore, Menacyn scientists have developed a pow-
erful new synthetic allergen, called Hisrallergen, which
provokes a histamine storm, that cannot be relieved with
anti-histamines in people deprived of Bif-orchestrated
immune development, and which causes non-stop
sneezing the whole day long. Hisrallergen, or HAG for
short, is readily distributed by amateur drones. The
resulting diminished visual acuity and mental attention,
and the messing up of keyboards downstream of noses,
means that anyone using a computer makes constant
errors: imagine what this will, for example, do to the daily
business of the world’s ﬁnancial centres!
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Bondage: Interesting. . . and I daresay that Menacyn has
done all this for a reason that you would like to
communicate to HM Government?
von Spectre: Exactly; that is the purpose of this evening’s
te^te-a te^te, or J€ager-Train. . . shall we order another?
Miss: same again, please!
As I was saying, we have the wherewithal to eliminate
Bif in countries we target with our anti-Bif viruses, and
thereby create health and economic havoc. Additionally,
we have Menacynbif, which is not affected by the anti-Bif
viruses and orchestrates correct immune development.
We now propose to offer HMGov access to Menacynbif
for the entire population of the UK and HM Overseas Ter-
ritories in return for the totality of its currency reserves,
including the rather pathetic amount of gold remaining
after the catastrophic ﬁre sale9 in the late 90s to early
00s. Since Menacynbif requires certain secret nutrients in
Bifgro, and dies without them, it will also be necessary to
enter into an irrevocable 100-year contract to purchase a
national supply of Bifgro annually. The alternative is
health and economic chaos for HM realm that would
ensue which, believe me – we have done the economic
evaluation10 calculations – would greatly exceed the cost
of access to Menacynbif.
Bondage: Okay, so that is the game. Unfortunately for
you, Mam, and your Menacyn cronies, MIH57
anticipated all this ages ago and has a neat defence in
the drawer. Let me enlighten you with a little bit of the
story. Some years ago, we commissioned the
development of a purely synthetic, genetically-stripped
down version of Bif, called Synbif, which has all the
desired immune stimulating properties of Bif, but is
entirely resistant to all known phages. The
microbiologists who developed Synbif – a strategic
alliance between the Lorenzo von Syntech High
Security Institute for Artiﬁcial Life in Madrid, headed by
the world-renowned Professor Vic Torde, and a secret
high-tech germ warfare defence group, reportedly
located at Porton Up! – also engineered into it a couple
of properties that make it super competitive, such that,
when ingested, it eliminates all other Bif strains. If and
when necessary, Synbif can be deployed anywhere in
the world to eliminate Menacynbif, and thereby
neutralise any security threat represented by
Menacynbif for the UK and its allies. Synbif, like
Menacynbif, also has speciﬁc nutritional requirements
that must be delivered as a dietary supplement called
Synbifgro, so it can itself be easily eliminated at any
point after deployment, once the all-clear is given, and
Bif can be safely returned to normal duty via a
probiotic.
von Spectre: Well done James! A wonderful impromptu
story! But: to have something like this, you would have
had to have done some pretty serious human trials that
would not have gone unnoticed, so I am rather sure that
Synbif is a ﬁgment of your imagination.
Bondage: Well, Mam, you can of course believe whatever
you wish, but I suppose that your Menacyn superiors will
be at least a little nervous. And. . . just to make them a tad
more nervous, I’ll give you a little more intelligence. Three
secret trials were indeed carried out: one by us on a well-
populated island off HM coast, and subsequently two of
our Southern European allies each carried out a trial on
one of their offshore islands. Obviously, the results have
not been published, but all trials were successful.
von Spectre: This also does not appear credible: the
famed transparency of the democratic British system would
have created an uproar, so I cannot imagine HMGov
wanting to run the risk of an adverse public reaction.
Bondage: Actually old sport, HMGov is not always as
transparent as one might imagine and, since the folks on
the island in question pay very little tax, and thus have
little clout with the Treasury, and hence HMGov in
general, MIH57 was not too concerned. So, actually I
think it is Menacyn that is now on the back foot. It
seems that we might have yet again achieved stalemate.
Miss! Please bring us that bottle of 1990 Romanee-Conti
I asked you to order for this evening: we both need to
re-educate our palates!
Bar person: Sorry, Sir: your favourite wine purveyor in
St. James’s Street ran out of the 1990 vintage on bonus
day and could only provide the 1989.
Bondage: Dinna worry lass, the 1989 is also reasonably
drinkable and will save HMGov about a grand.
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